Our finding of obestatin’s stimulatory effect on insulin combined with the other beneficial effects of obestatin on β-cells, makes obestatin an extremely attractive multifunctional therapeutic candidate for Type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.